Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs

Conditions:   Leg Ulcer;   Veins, Varicose;   Venous Ulcer;   Reflux;   Venous Reflux;   Venous Leg Ulcer;   Varicose Veins;   Varicose Ulcer;   Varicose Veins Leg
Intervention:   Drug: Polidocanol Endovenous Microfoam (PEM)
Sponsors:   OhioHealth;   BTG International Inc.
Not yet recruiting - verified December 2016

SToP: Venous Thromboembolism Screening in the Trauma Population

Conditions:   Venous Thromboembolism;   Deep Vein Thrombosis;   Trauma, Multiple
Interventions:   Other: Duplex ultrasound surveillance;   Other: No ultrasound surveillance
Sponsor:   Intermountain Health Care, Inc.
Not yet recruiting - verified November 2016

Leiden Trial In Prevention of Post-Operative ThromboEmbolic Events

Condition:   Deep-Venous Thrombosis
Interventions:   Device: IPD Device delivered by Converis;   Drug: Fraxiparine
Sponsors:   Leiden University Medical Center;   Medtronic - MITG
Not yet recruiting - verified December 2016

PREVENTion of Clot in Orthopaedic Trauma

Conditions:   Blood Clot;   Trauma
Interventions:   Drug: Acetylsalicylic acid;   Drug: Low Molecular Weight Heparin (LMWH)
Sponsors:   Major Extremity Trauma Research Consortium;   Patient-Centered Outcomes Research Institute
Not yet recruiting - verified December 2016

Pradaxa or Warfarin for Prevention of Recurrent DVT in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy

Conditions:   Dabigatran Etexilate;   Recurrence of DVT;   Pulmonary Embolism;   Warfarin
Interventions:   Drug: Dabigatran Etexilate;   Drug: Warfarin;   Procedure: angiography, tensiometry of pulmonary artery, catheter thrombus fragmentation;   Drug: Pradaxa;   Device: PigTail catheter
Sponsors:   Meshalkin Research Institute of Pathology of Circulation;   Boehringer Ingelheim
Recruiting - verified November 2016

Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus

Condition:   Left Ventricular Thrombosis
Interventions:   Drug: Apixaban 5 MG Oral Tablet [ELIQUIS];   Drug: Warfarin Sodium
Sponsors:   University of Science Malaysia;   INSTITUT JANTUNG NEGARA
Recruiting - verified November 2016

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Condition:   Anaemia
Interventions:   Drug: Daprodustat;   Drug: Darbepoetin alfa;   Drug: Placebo;   Drug: Iron Therapy
Sponsor:   GlaxoSmithKline
Recruiting - verified December 2016

Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery

Conditions:   Pregnancy Complications;   Hemorrhage
Interventions:   Drug: tranexamic acid 1 g (TA1);   Drug: tranexamic acid 0.5 g (TA1/2);   Drug: Saline Solution (TA0)
Sponsors:   University Hospital, Lille;   Ministry of Health, France;   French Health Products Safety Agency
Recruiting - verified December 2016

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

Conditions:   Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot
Interventions:   Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
Sponsors:   Alliance Foundation Trials, LLC.;   Patient-Centered Outcomes Research Institute
Recruiting - verified December 2016

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Condition:   Venous Thrombosis and Pulmonary Embolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified December 2016

Polidocanol Versus Glucose Treatment of Telangiectasia Trial

Conditions:   Varicose Veins;   Telangiectasis
Interventions:   Drug: Glucose;   Drug: Polidocanol with Glucose
Sponsors:   UPECLIN HC FM Botucatu Unesp;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Completed - verified November 2016

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

Conditions:   Deep Vein Thrombosis;   Post-Thrombotic Syndrome;   Venous Thrombosis
Interventions:   Drug: Recombinant tissue plasminogen activator (rt-PA);   Drug: Standard Anticoagulation Therapy
Sponsors:   University of Colorado, Denver;   RTI International;   Mid America Heart Institute;   National Heart, Lung, and Blood Institute (NHLBI);   Genentech, Inc.
Not yet recruiting - verified November 2016

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified November 2016

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Conditions:   Cancer;   Deep-vein Thrombosis of the Lower and Upper Extremities;   Pulmonary Embolism;   Non-valvular Atrial Fibrillation
Intervention:   Other: Retrospective Chart Review
Sponsors:   M.D. Anderson Cancer Center;   Janssen Scientific Affairs, LLC
Recruiting - verified December 2016

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:  
Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2016

Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis

Condition:   Venous Thrombosis
Interventions:   Device: a manual spiral thrombus broken suction device;   Procedure: catheter-directed thrombolysis;   Drug: low-molecular-weight heparin calcium;   Drug: urokinase
Sponsor:   Xuzhou Medical University
Enrolling by invitation - verified December 2016

D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs

Condition:   Deep Vein Thrombosis
Intervention:   Other: Diagnostic tests for suspected deep vein thrombosis
Sponsor:   G. d'Annunzio University
Recruiting - verified December 2016

A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics

Conditions:   Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Coagulopathies;   Pulmonary Embolism
Interventions:   Genetic: Genotype-guided;   Other: Standard-of-Care
Sponsors:   University of Puerto Rico;   National Institute on Minority Health and Health Disparities (NIMHD);   Genomas, Inc
Recruiting - verified November 2016

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Conditions:   Hypercortisolism;   Cushing Syndrome
Interventions:   Procedure: Adrenalectomy;   Other: Observation
Sponsors:   National Cancer Institute (NCI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   CC-OADRIS
Recruiting - verified September 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified December 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified December 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified December 2016

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Recruiting - verified August 2016

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia

Conditions:   Medical Patient;   Thrombocytopenia
Intervention:   Drug: Fondaparinux
Sponsor:   G. d'Annunzio University
Active, not recruiting - verified May 2016

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Condition:   Unsuspected Pulmonary Embolism
Intervention:   Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
Sponsor:   G. d'Annunzio University
Recruiting - verified December 2016

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Conditions:   Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention:   Drug: Recombinant tissue plasminogen activator (rt-PA)
Sponsors:   Washington University School of Medicine;   McMaster University;   Ontario Clinical Oncology Group (OCOG);   National Heart, Lung, and Blood Institute (NHLBI);   BSN Medical Inc;   Genentech, Inc.;   Medtronic - MITG;   Boston Scientific Corporation;   Mid America Heart Institute;   Society of Interventional Radiology Foundation;   Massachusetts General Hospital
Active, not recruiting - verified November 2016

High-dose Periop Statins for Prevention of DVT

Condition:   Gynecologic Oncological Pelvic/Abdominal Surgery
Intervention:   Drug: atorvastatin
Sponsors:   Yale University;   Washington Mutual Foundation
Completed - verified November 2016